Drug intelligence / Profile preview

Dingluo nasal drops

Development stage
Unknown
Lead developer
Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Intranasal
01

Overview

Dingluo nasal drops is a Traditional Chinese Medicine (TCM) formulation developed by Dongzhimen Hospital, Beijing University of Chinese Medicine, for the acute treatment of migraine attacks. The drug is administered intranasally, a route intended to facilitate rapid absorption and potentially direct delivery to the central nervous system via the olfactory and trigeminal nerve pathways, thereby bypassing the blood-brain barrier. The formulation is based on the TCM therapeutic principle of extinguishing wind and stabilizing the collaterals to address the underlying pathology of vascular headaches. It is currently undergoing clinical evaluation in China to assess its efficacy in reducing pain intensity and associated symptoms during acute migraine episodes in adults.

Other names
Dingluo Di Bi Ye

Beyond the preview

Go deeper on Dingluo nasal drops.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dingluo nasal drops.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call